FGFR1 and head and neck squamous cell carcinoma: On the one hand, it is reported that FGFR1 amplification is a frequent event (Göke et al., 2013) and might act as a candidate prognostic biomarker in primary and metastatic HNSCC (Koole et al., 2016).